Building Best-in-Class Medical Affairs Capabilities In India – Structure and Challenges in Emerging Markets

STUDY OVERVIEW

Pharmaceutical Medical Affairs organizations bridge the gap between commercial and R&D operations and hence are critical for biopharma and medical device organization future growth. In fact, the call for increased transparency in the recent years has increased the responsibility of Medical Affairs at many companies. However, Medical Affairs at many companies in emerging countries, especially India, is still in its infancy. Moreover, Medical Affairs groups in India lack clear value proposition to evolve beyond their traditional role.

Best Practices, LLC's recent case study illustrates how mature and Indian biopharmaceutical companies are structuring and managing their Medical Affairs organizations today. The study also reviews the regulatory landscape in India and the key challenges facing Medical Affairs groups there.

KEY TOPICS

• Medical Affairs: Scope & Structure
• Medical Affairs: Leadership & Oversight
• Medical Affairs: Regulatory Landscape & Challenges
• Participant Demographic Data

• Medical Affairs group dedication
• Departmental reporting relationships
• Job level or Medical Affairs head
• Geographic span of organization
• Top three success factors for developing and maintaining effective Medical Affairs group
• Top three challenges for developing and maintaining effective Medical Affairs group

• Mature Market Medical Affairs Reporting into R&D, Becoming Own Entity; India Medical Affairs Reporting to Commercial: Four out of 10 mature market groups in the benchmark class report to R&D. As a function, Medical Affairs tends to more aligned with R&D, reflecting a common drive to differentiate itself from the commercial side of the organization. However, half of India segment participants report into Commercial/Marketing highlighting the fact that MA in India is still in formative stages.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.